Search This Blog

Thursday, July 25, 2019

West Pharmaceutical EPS beats by $0.17, beats on revenue

West Pharmaceutical (NYSE:WST): Q2 Non-GAAP EPS of $0.89 beats by $0.17; GAAP EPS of $0.88 beats by $0.15.
Revenue of $469.7M (+5.0% Y/Y) beats by $9.8M.
Shares -0.39% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)